Skip to main content
. 2021 Nov 24;13(12):1994. doi: 10.3390/pharmaceutics13121994

Figure 1.

Figure 1

Risk factors (described in red) contributing to the development of osteoarthritis (OA). Description of structural alteration and chondrocyte-specific changes in osteoarthritis (described in black). ECM: Extracellular matrix; SASP: Senescence-associated secretory phenotype. Adapted from [12], MDPI, 2017.